Imunon, Inc. (IMNN)
NASDAQ · Healthcare
Imunon, Inc. EBITDA 2017–2022
Imunon, Inc. annual/quarterly ebitda history and growth rate from 2017 to 2022. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Imunon, Inc. ebitda for the quarter ending March 31, 2022 was -5.7 M, a 9.15% increase year-over-year.
- Imunon, Inc. ebitda for the twelve months ending March 31, 2022 was -20.1 M.
- Imunon, Inc. annual ebitda for 2022 was -24.2 M, a 19.14% increase from 2021.
- Imunon, Inc. annual ebitda for 2021 was -20.3 M, a 14.42% increase from 2020.
- Imunon, Inc. annual ebitda for 2020 was -17.7 M, a 10.58% decrease from 2019.
- Imunon, Inc. annual ebitda for 2019 was -19.8 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Imunon, Inc. EBITDA — FAQ
Imunon, Inc. (IMNN) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNN's ebitda history?
The chart and table above show Imunon, Inc.'s ebitda by year and by quarter, including the growth rate.